iron bisglycinate low dose
Selected indexed studies
- Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies. (J Pregnancy, 2024) [PMID:39582678]
- Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients. (J Chin Med Assoc, 2022) [PMID:35358119]
- Assessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range among Healthy Premenopausal Women with Iron Deficiency without Anemia. (Nutrients, 2023) [PMID:37299583]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies. (2024) pubmed
- Assessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range among Healthy Premenopausal Women with Iron Deficiency without Anemia. (2023) pubmed
- Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial. (2023) pubmed
- Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients. (2022) pubmed
- Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. (2014) pubmed
- Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate. (2024) pubmed
- Toxicology and safety of Ferrochel and other iron amino acid chelates. (2001) pubmed